| Pathogenic germline variants in 10,389 adult cancers K Huang, RJ Mashl, Y Wu, DI Ritter, J Wang, C Oh, M Paczkowska, ... Cell 173 (2), 355-370. e14, 2018 | 700 | 2018 |
| Driver fusions and their implications in the development and treatment of human cancers Q Gao, WW Liang, SM Foltz, G Mutharasu, RG Jayasinghe, S Cao, ... Cell reports 23 (1), 227-238. e3, 2018 | 475 | 2018 |
| Integrated proteogenomic characterization of clear cell renal cell carcinoma DJ Clark, SM Dhanasekaran, F Petralia, J Pan, X Song, Y Hu, ... Cell 179 (4), 964-983. e31, 2019 | 439 | 2019 |
| The human tumor atlas network: charting tumor transitions across space and time at single-cell resolution O Rozenblatt-Rosen, A Regev, P Oberdoerffer, T Nawy, A Hupalowska, ... Cell 181 (2), 236-249, 2020 | 375 | 2020 |
| Perspective on oncogenic processes at the end of the beginning of cancer genomics L Ding, MH Bailey, E Porta-Pardo, V Thorsson, A Colaprico, D Bertrand, ... Cell 173 (2), 305-320. e10, 2018 | 350 | 2018 |
| Patterns and functional implications of rare germline variants across 12 cancer types C Lu, M Xie, MC Wendl, J Wang, MD McLellan, MDM Leiserson, K Huang, ... Nature communications 6 (1), 10086, 2015 | 298 | 2015 |
| Systematic analysis of splice-site-creating mutations in cancer RG Jayasinghe, S Cao, Q Gao, MC Wendl, NS Vo, SM Reynolds, Y Zhao, ... Cell reports 23 (1), 270-281. e3, 2018 | 217 | 2018 |
| Before and after: comparison of legacy and harmonized TCGA genomic data commons’ data GF Gao, JS Parker, SM Reynolds, TC Silva, LB Wang, W Zhou, R Akbani, ... Cell systems 9 (1), 24-34. e10, 2019 | 133 | 2019 |
| Systematic discovery of complex insertions and deletions in human cancers K Ye, J Wang, R Jayasinghe, EW Lameijer, JF McMichael, J Ning, ... Nature medicine 22 (1), 97-104, 2016 | 118 | 2016 |
| Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial EA Bohula, BM Scirica, SE Inzucchi, DK McGuire, AC Keech, SR Smith, ... The Lancet 392 (10161), 2269-2279, 2018 | 86 | 2018 |
| Co-evolution of tumor and immune cells during progression of multiple myeloma R Liu, Q Gao, SM Foltz, JS Fowles, L Yao, JT Wang, S Cao, H Sun, ... Nature communications 12 (1), 2559, 2021 | 84 | 2021 |
| Spatially restricted drivers and transitional cell populations cooperate with the microenvironment in untreated and chemo-resistant pancreatic cancer D Cui Zhou, RG Jayasinghe, S Chen, JM Herndon, MD Iglesia, P Navale, ... Nature genetics 54 (9), 1390-1405, 2022 | 77 | 2022 |
| Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatment H Sun, S Cao, RJ Mashl, CK Mo, S Zaccaria, MC Wendl, SR Davies, ... Nature communications 12 (1), 5086, 2021 | 71 | 2021 |
| Divergent viral presentation among human tumors and adjacent normal tissues S Cao, MC Wendl, MA Wyczalkowski, K Wylie, K Ye, R Jayasinghe, M Xie, ... Scientific reports 6 (1), 28294, 2016 | 70 | 2016 |
| CTCF genetic alterations in endometrial carcinoma are pro-tumorigenic AD Marshall, CG Bailey, K Champ, M Vellozzi, P O'Young, C Metierre, ... Oncogene 36 (29), 4100-4110, 2017 | 59 | 2017 |
| Integrated proteogenomic characterization of clear cell renal cell carcinoma DJ Clark, SM Dhanasekaran, F Petralia, J Pan, X Song, Y Hu, ... Cell 180 (1), 207, 2020 | 52 | 2020 |
| A long-acting interleukin-7, rhIL-7-hyFc, enhances CAR T cell expansion, persistence, and anti-tumor activity MY Kim, R Jayasinghe, JM Devenport, JK Ritchey, MP Rettig, J O’Neal, ... Nature communications 13 (1), 3296, 2022 | 37 | 2022 |
| Evolution and structure of clinically relevant gene fusions in multiple myeloma SM Foltz, Q Gao, CJ Yoon, H Sun, L Yao, Y Li, RG Jayasinghe, S Cao, ... Nature communications 11 (1), 2666, 2020 | 37 | 2020 |
| Discovery of driver non-coding splice-site-creating mutations in cancer S Cao, DC Zhou, C Oh, RG Jayasinghe, Y Zhao, CJ Yoon, ... Nature communications 11 (1), 5573, 2020 | 29 | 2020 |
| Motixafortide and G-CSF to mobilize hematopoietic stem cells for autologous transplantation in multiple myeloma: a randomized phase 3 trial ZD Crees, MP Rettig, RG Jayasinghe, K Stockerl-Goldstein, SM Larson, ... Nature medicine 29 (4), 869-879, 2023 | 22 | 2023 |
